Reagents News and Research

RSS

Illumina launches TruSeq SBS Sequencing kit

Illumina, Inc. today announced the launch of its TruSeq SBS Sequencing kit that will enable high-quality paired end reads of 150 base pairs (bp), increase the output of high-quality base calls, and enhance throughput to greater than 95 Gigabases (Gb) of high-quality base pairs per run on Illumina's Genome Analyzer (GA) sequencing system.

From Illumina, Inc. 26 Jul 2010

Asuragen reports collaborative study results of advanced PCR-based molecular profiling of FMR1 gene

Asuragen, Inc. announced today the results from two collaborative studies, one with the University of California Davis M.I.N.D. Institute and another with Rush University Medical Center, that demonstrate comprehensive molecular profiling of the Fragile X Mental Retardation (FMR1) gene using advanced PCR-based methods.

26 Jul 2010

Roche, Exiqon join marketing forces for RealTime ready assays, microRNA PCR systems

Roche and Exiqon join marketing forces for Roche Applied Science's RealTime ready assays and Exiqon`s miRCURY LNA Universal RT microRNA qPCR system. As indicated by respective links on their websites, each system will complement the cooperator's product portfolio.

21 Jul 2010

INRA Genomic Platform core facility now provides services on Fluidigm's BioMark System for Genetic Analysis

Fluidigm Corporation today announced that the Toulouse Midi-Pyrénées Genomic Platform - Genotoul INRA core facility is now providing a wide range of services on a BioMark™ System for Genetic Analysis to a wide range of French researchers. These services include SNP genotyping, gene expression analysis and digital PCR quantification of DNA libraries for next-generation sequencing. The INRA has been validating the performance of the system on several projects over the past year.

21 Jul 2010

Patent application for inexpensive CyPath assay filed by Biomoda

Cancer diagnostics company Biomoda,filed a U.S. patent application on a quantitative method for scoring cells labeled with the CyPath® assay to determine whether cells are dysplastic or carcinomic by measuring the photon emission rate.

21 Jul 2010

Meridian Bioscience third-quarter net sales decrease 11% to $33.9 million

Net sales for the third quarter of fiscal 2010 were $33,857,000 as compared to $38,240,000 for the same period of the prior fiscal year, a decrease of 11%. Net earnings for the third quarter of fiscal 2010 were $6,424,000 or $0.16 per diluted share, both decreases of 24%, compared to the third quarter of fiscal 2009. (Net earnings include $673,000 in Bioline acquisition costs or $0.01 per diluted share.) Diluted common shares outstanding for fiscal 2010 and 2009 were 41,151,000 and 41,191,000, respectively.

20 Jul 2010

Meridian Bioscience completes acquisition of Bioline group of companies

Meridian Bioscience, Inc., Cincinnati, Ohio announces that effective today it will have completed the purchase of all the outstanding capital stock of the Bioline group of companies consisting of Bioline Ltd (UK), Bioline GmbH (Germany), Bioline (Aust) Pty Ltd (Australia), Bioline Reagents Ltd, and Bioline USA, Inc for $23.3 million in cash on hand.

20 Jul 2010

Corgenix, ELITech establish broad strategic alliance

Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, and the ELITech Group, a Paris, France-based, privately held group of companies and worldwide manufacturer and distributor of in-vitro diagnostic equipment and reagents, today announced a broad strategic alliance.

19 Jul 2010

Florida Institute of Technology assists licensing CDNI-Glu compound to UK company

As a national research university, Florida Institute of Technology not only involves its students in research, but also seeks to license and patent its many innovations. An example of recently licensed university technology is a chemical compound that facilitates the work of neuroscientists in the laboratory.Associate Professor Nasri Nesnas was familiar as a chemist with the chemical compound CDNI-Glu, a commonly used laboratory research tool. Most often, neuroscientists use it to study the brain's neural networks by improving the localization of synaptic stimulation

17 Jul 2010

Thermo Fisher Scientific completes Fermentas acquisition

Thermo Fisher Scientific Inc., the world leader in serving science, has completed its previously announced acquisition of Fermentas International Inc. With Fermentas' broad range of high-quality molecular and cellular biology research tools, including reagents, enzymes and kits, Thermo Fisher can offer a complete workflow for genomics research while building on its platform of PCR and qPCR tools and resources.

From Thermo Fisher Scientific Inc. 17 Jul 2010

NanoString Technologies increases throughput of nCounter Analysis System

NanoString Technologies, Inc., a privately held life sciences company marketing a novel digital molecular barcoding technology for detecting and counting large sets of targets in biological samples, today announced that it has increased the throughput of its nCounter Analysis System by expanding its multiplexing capacity to 800 gene transcripts per reaction.

From NanoString Technologies 15 Jul 2010

ZyGEM launches new microbial fingerprinting diagnostic technology

ZyGEM Corp. Ltd., has introduced its new microbial fingerprinting diagnostic technology that is expected to dramatically reduce the complexity and time needed to identify unknown infectious agents in mixed population samples. The approach is designed to run on the company's new MicroLab platform and has the potential to accurately identify up to 30 types of microbes simultaneously from a single sample in less than an hour.

14 Jul 2010

Commercial cholesterol measurement techniques produce mixed results: Study

The National Cholesterol Education Program maintains guidelines to assess the accuracy of methods for measuring cholesterol levels in patients. A recent study published in the journal Clinical Chemistry found that seven leading commercial methods produce results of mixed accuracy when compared to well-established techniques.

14 Jul 2010

NEB introduces NEBNext Quick DNA Sample Prep Reagent Set 2, Master Mix Set 2

New England Biolabs has expanded its line of reagents for sample preparation with the introduction of NEBNext Quick DNA Sample Prep Reagent Set 2 and Master Mix Set 2, both suitable for library construction for Roche's 454 GS FLX Titanium and GS Junior instruments. These new products provide all the necessary enzymes and buffers for fast fragment library preparation.

From New England Biolabs 14 Jul 2010

LSBio announces exclusive distribution agreements with select strategic partners

LifeSpan BioSciences, Inc., a leading provider of antibodies to researchers worldwide, today announced exclusive distribution agreements with select strategic partners making the full LSBio catalog of 75,000 antibodies, including 3,600 IHC-validated, IHC-plus antibodies, available around the globe.

14 Jul 2010

Palex to distribute MDI's Detect-Ready MRSA assay in Spain

Molecular Detection Inc. (MDI), a company developing Detect-Ready™ assays designed to increase the speed and accuracy of infectious disease diagnosis, and Palex Medical S.A., one of Spain's leading distributors of medical device and diagnostic products to hospitals, today announced that they have entered into an exclusive distribution agreement for MDI's Detect-Ready™ MRSA assay in Spain.

13 Jul 2010

Vivakor expands distribution channels of VivaThermic vials

Vivakor, Inc. announced that it has expanded United States distribution of its VivaThermic vials. A listing of Authorized Distributors of VivaThermic vials is available at www.vivathermic.com/distributors.

13 Jul 2010

Sysmex announces three-year, dual source urinalysis contract agreement with Amerinet

Sysmex, a global leader in medical diagnostic testing equipment and information systems technology, today announced a three-year, dual source urinalysis contract agreement with Amerinet. Amerinet members have immediate purchasing/leasing access to Sysmex automated urine particle analyzers, reagents, controls, and service.

From Sysmex America, Inc. 9 Jul 2010

SAIC-Frederick, Fluidigm collaborate to decode entire genome of Epstein-Barr virus

SAIC-Frederick, Inc. and Fluidigm Corporation are collaborating to decode the entire genome of the Epstein-Barr virus (EBV) using technology that can speed up research on the genetic basis of cancer and other diseases.

1 Jul 2010

Diagnostic Hybrids receives Chinese SFDA approval for D3 Ultra DFA Respiratory Virus Screening and ID Kit

Diagnostic Hybrids, a Quidel Company, received approval from the People's Republic of China's State Food and Drug Administration (SFDA) for its D3 Ultra DFA Respiratory Virus Screening and ID Kit. The D3 Ultra DFA Respiratory Virus Screening and ID Kit is a direct fluorescence assay (DFA) that provides rapid, sensitive and specific screening and identification of Influenza A, Influenza B, Parainfluenza 1, 2, & 3, Respiratory Syncytial Virus and Adenovirus.

1 Jul 2010

Reagents News and Research

Illumina launches TruSeq SBS Sequencing kit

Asuragen reports collaborative study results of advanced PCR-based molecular profiling of FMR1 gene

Roche, Exiqon join marketing forces for RealTime ready assays, microRNA PCR systems

INRA Genomic Platform core facility now provides services on Fluidigm's BioMark System for Genetic Analysis

Patent application for inexpensive CyPath assay filed by Biomoda

Meridian Bioscience third-quarter net sales decrease 11% to $33.9 million

Meridian Bioscience completes acquisition of Bioline group of companies

Corgenix, ELITech establish broad strategic alliance

Florida Institute of Technology assists licensing CDNI-Glu compound to UK company

Thermo Fisher Scientific completes Fermentas acquisition

NanoString Technologies increases throughput of nCounter Analysis System

ZyGEM launches new microbial fingerprinting diagnostic technology

Commercial cholesterol measurement techniques produce mixed results: Study

NEB introduces NEBNext Quick DNA Sample Prep Reagent Set 2, Master Mix Set 2

LSBio announces exclusive distribution agreements with select strategic partners

Palex to distribute MDI's Detect-Ready MRSA assay in Spain

Vivakor expands distribution channels of VivaThermic vials

Sysmex announces three-year, dual source urinalysis contract agreement with Amerinet

SAIC-Frederick, Fluidigm collaborate to decode entire genome of Epstein-Barr virus

Diagnostic Hybrids receives Chinese SFDA approval for D3 Ultra DFA Respiratory Virus Screening and ID Kit

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News